Dermatology

Pediatric patients with alopecia areata (AA) may experience a severe burden of disease that can have negative emotional and financial effects. Pediatric AA affects not only the patients themselves but also their families, which warrants appropriate medical support from physicians. Alopecia areata (AA) is an autoimmune disorder characterized by chronic hair loss. Although it’s not...

Although vitiligo is not considered life-threatening and is not associated with severe physical symptoms, the condition can still significantly impact patients’ quality of life. Due to stares and the disease’s unpredictable course, many vitiligo patients feel distressed and stigmatized by their condition. Vitiligo support groups may alleviate these feelings and potentially improve the quality of...

Many vitiligo patients experience access to care issues, such as a lack of insurance, language barriers, geographic proximity to a provider, and more. Unfortunately, these barriers lead to vitiligo treatment delays. Delayed treatment can interfere with disease stabilization and repigmentation efficacy as early-stage interventions are more effective. Given that patients of color with vitiligo experience...

Vitiligo is a common skin condition associated with many comorbid autoimmune, dermatological, and systemic diseases. These conditions include diabetes mellitus, rheumatoid arthritis, Addison’s disease, inflammatory bowel disease, scleroderma, and more. However, the researchers recognized that very few studies investigated the associations between vitiligo and various medical conditions. Therefore, this study, published by The Journal of...

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_spacing=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_shadow=”none” column_border_radius=”none” column_link_target=”_self” column_position=”default” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1/1″ tablet_width_inherit=”default” tablet_text_alignment=”default” phone_text_alignment=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][vc_column_text]Health insurance coverage is strongly related to better health care outcomes. Individuals without insurance or those who...

In the medical community, an often overlooked yet important issue is the psychosocial distress experienced by people of color with vitiligo. Although vitiligo affects all racial groups similarly, this skin pigmentation condition is much more noticeable in people with darker skin.  Racially diverse children are more likely to encounter barriers to accessing care at pediatric...

Atopic dermatitis is the most prevalent skin disease. Up to 25 percent of children and 8 percent of adults have a current or past atopic dermatitis diagnosis. Atopic dermatitis negatively affects the quality of life and disrupts sleep at night due to itch. In addition to asthma and allergies, atopic dermatitis comorbidities can lead to:...

Opzelura can be used twice daily in patients ages 12 years and older The U.S. Food and Drug Administration has approved Opzelura (ruxolitinib) as the first topical treatment for vitiligo. The 1.5 percent cream is approved for continuous topical use twice daily to affected areas of up to 10 percent of body surface area in...

Racial differences have been observed in the prevalence and presentation of atopic dermatitis in African American and European American patients. African Americans tend to present with extensive papular lesions and widespread extensor surface involvement, as well as lichenification secondary to treatment resistance. Few studies have been conducted on the immune signatures that may drive disease,...